Related Experiment Video
Updated: Jul 13, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Berberine--a novel approach to cholesterol lowering
1School of Biomedical Sciences, The University of Queensland, QLD 4072, Australia. s_doggrell@yahoo.com
Expert Opinion on Investigational Drugs
|June 2, 2005
Summary
Berberine lowers LDL-cholesterol by stabilizing LDLR mRNA, similar to statins. While not a direct statin alternative, berberine
Area of Science:
- Biochemistry
- Pharmacology
- Cardiovascular Medicine
Background:
- Statins effectively lower LDL-cholesterol but do not eliminate cardiovascular disease risks.
- Berberine offers an alternative mechanism for LDL receptor (LDLR) upregulation.
Purpose of the Study:
- To investigate berberine's lipid-lowering effects and compare its mechanism to statins.
- To evaluate berberine's potential in managing hypercholesterolemia and cardiovascular disease.
Main Methods:
- Animal studies using high-fat, high-cholesterol diets in hamsters.
- Clinical trials with hypercholesterolemic subjects administered berberine hydrochloride.
- Analysis of serum lipid profiles, including total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides.
Main Results:
- Berberine significantly reduced total and LDL-cholesterol in hamsters and hypercholesterolemic humans.
- Berberine lowered triglyceride levels without affecting HDL-cholesterol.
- Berberine upregulates LDLR via LDLR mRNA stabilization, distinct from statins.
Conclusions:
- Berberine demonstrates potent lipid-lowering effects comparable to statins through LDLR upregulation.
- While its lipid-lowering mechanism overlaps with statins, berberine's additional cardiovascular benefits warrant consideration for disease management.
Related Concept Videos
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...